Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 46 AL 60

The blood-brain barrier as a treatment target for neurodegenerative disorders

Rust R, Sagare AP, Zhang M, Zlokovic BV, Kisler K.

Expert Opin Drug Deliv. 2025 May;22(5):673-692. doi: 10.1080/17425247.2025.2480654. Epub 2025 Mar 21.

Potential therapeutic targets for Alzheimer's disease: Fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy

Li Y, Yang C, Liu X, Shu J, Zhao N, Sun Z, Tabish MS, Hong Y, Liu E, Wei N, Sun M.

Neuroscience. 2025 May 7;573:42-51. doi: 10.1016/j.neuroscience.2025.03.009. Epub 2025 Mar 15.

Innovative approaches in acetylcholinesterase inhibition: a pathway to effective Alzheimer's disease treatment

Arora P, Swati, Rani S, Jha S, Gupta S, Kumar S.

Mol Divers. 2025 Dec;29(6):5367-5396. doi: 10.1007/s11030-025-11170-1. Epub 2025 Mar 24.

Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer's Disease

Zhou Q, Wang W, Deng C.

Mol Neurobiol. 2025 Aug;62(8):9686-9709. doi: 10.1007/s12035-025-04838-0. Epub 2025 Mar 25.

Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?

Azarfar K, Decourt B, Sanchez Camacho B, Lawrence JJ, Omondi TR, Sabbagh MN.

Expert Rev Neurother. 2025 May;25(5):521-535. doi: 10.1080/14737175.2025.2483928. Epub 2025 Apr 3.

Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer's disease

Marco-Contelles JL, Oset-Gasque MJ.

Chem Biol Interact. 2025 May 25;413:111497. doi: 10.1016/j.cbi.2025.111497. Epub 2025 Mar 28.

Immune modulation to treat Alzheimer's disease

Duggan MR, Morgan DG, Price BR, Rajbanshi B, Martin-Peña A, Tansey MG, Walker KA.

Mol Neurodegener. 2025 Mar 31;20(1):39. doi: 10.1186/s13024-025-00828-x.

Infections, genetics, and Alzheimer's disease: Exploring the pathogenic factors for innovative therapies

Kordi R, Andrews TJ, Hicar MD.

Virology. 2025 Jun;607:110523. doi: 10.1016/j.virol.2025.110523. Epub 2025 Mar 27.

Reducing Alzheimer's disease risk with SGLT2 inhibitors: From glycemic control to neuroprotection

Alami M, Morvaridzadeh M, El Khayari A, Boumezough K, El Fatimy R, Khalil A, Fulop T, Berrougui H.

Ageing Res Rev. 2025 Jun;108:102751. doi: 10.1016/j.arr.2025.102751. Epub 2025 Apr 7.

Unveiling the Protective Roles of Melatonin on Glial Cells in the Battle Against Alzheimer's Disease-Insights from In Vivo and In Vitro Studies

Sirimaharaj N, Thiankhaw K, Chattipakorn N, Chattipakorn SC.

Mol Neurobiol. 2025 Aug;62(8):10414-10426. doi: 10.1007/s12035-025-04904-7. Epub 2025 Apr 10.

The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

Divecha YA, Rampes S, Tromp S, Boyanova ST, Fleckney A, Fidanboylu M, Thomas SA.

Pharmacol Rev. 2025 May;77(3):100052. doi: 10.1016/j.pharmr.2025.100052. Epub 2025 Mar 13.

Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer's Disease

Bogadi S, Bhaskaran M, Ravichandran V, Nesamony J, Chelliah S, Kuppusamy G, Prakash GM, Karri VVSR, Mallick S, Farahim F, Ali T, Babu DR, Subramaniyan V.

Mol Neurobiol. 2025 Aug;62(8):10915-10934. doi: 10.1007/s12035-025-04917-2. Epub 2025 Apr 16.

Reactive Oxygen Species as a Common Pathological Link Between Alcohol Use Disorder and Alzheimer's Disease with Therapeutic Implications

Song H, Lee J, Lee Y, Kim S, Kang S.

Int J Mol Sci. 2025 Apr 1;26(7):3272. doi: 10.3390/ijms26073272.

Alzheimer's Disease and Polymeric Nanocarriers: Synergistic Advances in Targeted Drug Delivery

Kumar L, Rana R, Shaikh NK, Thakur A, Kashyap S, Aggarwal V, Jyothiraditya V.

Curr Top Med Chem. 2025;25(24):2829-2847. doi: 10.2174/0115680266347890250409153450.

Unraveling the Complexity of Alzheimer's Disease: Insights into Etiology and Advancements in Treatment Strategies

Khan B, Iqbal MK, Khan MA, Khan H, Kiyani MM, Bashir S, Li S.

J Mol Neurosci. 2025 Apr 25;75(2):57. doi: 10.1007/s12031-025-02337-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias